NF2 and neoplasm: In a comprehensive analysis, the methylation profiles were assessed in a cohort of 44 schwannoma tumour samples, comprising 37 schwannoma tumour samples, 29 from individuals without NF2 and 8 from patients diagnosed with NF2 [76].